Cover Image
市場調查報告書

藥物研發技術:全球市場概要

Drug Discovery Technologies - A Global Market Overview

出版商 Industry Experts 商品編碼 311350
出版日期 內容資訊 英文 248 Pages
訂單完成後即時交付
價格
Back to Top
藥物研發技術:全球市場概要 Drug Discovery Technologies - A Global Market Overview
出版日期: 2014年08月28日 內容資訊: 英文 248 Pages
簡介

全球藥物研發技術市場上,高通量篩檢佔最大的佔有率,2015年達到180億美元規模,預計約有30%的佔有率。接著,預測生物分析化驗設備約有140億美元規模。

本報告提供全球藥物研發技術市場相關調查分析、全球/地區市場分析與預測、主要企業等相關的系統性資訊。

A部分:全球市場預測

第1章 簡介

第2章 主要市場趨勢

  • 更快、智慧、廉價
  • 藉由鹵鍵
  • ALS為目標的幹細胞之新使用
  • 個人化醫療
  • 診斷、治療的確認
  • 瘧疾
  • 創新的方法
  • 3D的藥物篩檢
  • 3D的蛋白質製圖
  • 藥物研發和細胞染色的自動化
  • 電腦計劃的利用

第3章 藥物研發情形的最近專利

第4章 全球主要企業

  • 美國
  • 加拿大
  • 德國
  • 義大利
  • 冰島
  • 荷蘭
  • 俄羅斯
  • 瑞典
  • 瑞士
  • 英國
  • 奧地利
  • 中國
  • 日本
  • 以色列

第5章 主要景氣趨勢

第6章 全球市場概要

  • 市場概要:各技術

B部分:地區市場預測

地區市場概要

第1章 美國

  • 市場概要:各技術
  • 主要企業

第2章 歐洲

  • 市場概要:各技術
  • 主要企業

第3章 亞太地區

  • 市場概要:各技術
  • 主要企業

第4章 其他地區

  • 市場概要:各技術
  • 主要企業

C部分:產業指南

第1章 北美

  • 加拿大
  • 美國

第2章 歐洲

  • 比利時
  • 丹麥
  • 法國
  • 德國
  • 冰島
  • 愛爾蘭
  • 義大利
  • 俄羅斯
  • 瑞典
  • 瑞士
  • 荷蘭
  • 英國

第3章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 日本
  • 新加坡
  • 台灣

第4章 其他地區

  • 以色列

D部分:附錄

第1章 調查手法

第2章 回饋

圖表

目錄
Product Code: BT011

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening.

Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Others comprising Epigenetics, Metabolomics, Combinatorial Chemistry, Synthetic Biology, Systems Biology and Nanotechnology.

The global market value for the above mentioned technologies is analyzed in USD. High Throughput Screening accounts for a lion's share in global drug discovery technologies market with an expected share of about 30% in 2015 valued at $18 billion followed by Bioanalytical Assays or instruments by about $14 billion.

This 248 pages global market report includes 28 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 56 key global players and 67 major players across the United States - 41; Europe - 16; Asia-Pacific - 7; and Rest of World - 3. The research also provides the listing of the companies that are engaged in technology, contract research services and providers of discovery technologies. The global list of companies covers addresses, contact numbers and the website addresses of 186 companies.

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1. Product Outline
    • 1.1.1. Backdrop
    • 1.1.2. What Is Drug Discovery?
      • 1.1.2.1. Screening and Design
    • 1.1.3. Omics in Drug Discovery and Development
    • 1.1.4. Process of Discovering Improved Drugs Provided by a Technological Revolution
    • 1.1.5. Drug Discovery Technologies
      • 1.1.5.1. Bioanalytical Assays
        • 1.1.5.1.1. Bio-Analytical Techniques
        • 1.1.5.1.2. Sample Extraction
      • 1.1.5.2. Bioinformatics
        • 1.1.5.2.1. Computer-Aided Drug Design
      • 1.1.5.3. Cell Based Assays
        • 1.1.5.3.1. Cell-Based Assays in High-Throughput Screening for Drug Discovery
      • 1.1.5.4. Genomic Technologies
        • 1.1.5.4.1. Drug Discovery
        • 1.1.5.4.2. Clinical Medicine
        • 1.1.5.4.3. New Antibiotics
      • 1.1.5.5. High Throughput Screening
        • 1.1.5.5.1. High Throughput Screening in Drug Discovery
      • 1.1.5.6. Proteomic Technologies
        • 1.1.5.6.1. A Proteomics Approach to Biomarker Discovery and Drug Development
      • 1.1.5.7. Other Technologies
        • 1.1.5.7.1. Epigenetics
          • 1.1.5.7.1.1. Epigenetics and Cancer Treatment
        • 1.1.5.7.2. Metabolomics
          • 1.1.5.7.2.1. Target Identification
          • 1.1.5.7.2.2. Target Validation
          • 1.1.5.7.2.3. Lead Optimization
          • 1.1.5.7.2.4. Mode of Action
          • 1.1.5.7.2.5. Preclinical Studies
          • 1.1.5.7.2.6. Clinical Studies
          • 1.1.5.7.2.7. Post-Approval Studies
          • 1.1.5.7.2.8. Diagnostics
        • 1.1.5.7.3. Combinatorial Chemistry
          • 1.1.5.7.3.1. Chemical Encoding
          • 1.1.5.7.3.2. Positional Encoding
          • 1.1.5.7.3.3. Electronic Encoding
        • 1.1.5.7.4. Synthetic Biology
        • 1.1.5.7.5. Systems Biology
          • 1.1.5.7.5.1. Computer Modelling
        • 1.1.5.7.6. Nanotechnology

2. KEY MARKET TRENDS

  • 2.1. Drug Discovery Gets Faster, Smarter and Cheaper
  • 2.2. Drug Discovery Being Enabled through Halogen Bonds
  • 2.3. Drug Discovery Bolstered by New Use for Stem Cells in Targeting ALS
  • 2.4. Personalized Medicine: Advantage Patients, Disadvantage Drug Companies
  • 2.5. Identification of Diagnostic and Therapeutic Targets Better Enabled by Combining Plasma Screening and Genetic Screening
  • 2.6. Source of New Drug Category from Trapping Malaria Parasites inside Host Blood Cell
  • 2.7. Fighting Malaria Drug Resistance through an Innovative Method
  • 2.8. Drug Screening in 3D Using High-Throughput Chip
  • 2.9. Drug Discovery Expedited through 3D Protein Mapping
  • 2.10. Drug Discovery and Automated Cell Staining
  • 2.11. Drug Discovery and Development for Complex Disease Targets to be Alleviated through a Computer Program

3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE

  • USPTO Issues '979 Patent for Biohaven's Glutamate Modulating Agents to Treat GAD
  • Patents Issued for Suven's New Chemical Entities to treat Neurodegenerative Disorders
  • Japan Patent Office Approves Patent for C4XD's Technology
  • Additional Patents Issued on MorphoSys' Ylanthia in the US and in China
  • Sareum Receives a Patent for its Kinase Inhibitors in Japan
  • USPTO Grants Patent for Prima BioMed's CVac
  • Japan Patent Office Decides to Issue Patent for Marina's SMARTICLES® Nucleic Acid Delivery Technology
  • USPTO Grants a Patent in Regulus' Sarnow Patent Estate on microRNA Therapies to Treat HCV
  • USPTO Grants Patent for Kadimastem's Cell Technology
  • USPTO Grants a Novel Patent in Alnylam's McSwiggen Patent Estate
  • Suven Receives Patent Approval in the US for its Major Depressive Disorder Drug
  • Notice of Allowance for Canadian Patent Granted to VistaGen
  • Issue of Patent on Broad Institute's New Gene-Editing Method
  • US Patent Office Grants Patent for HUB's Method of Growing Organoids
  • Dyadic Granted US Patent for High Throughput Screening
  • US Patent Granted to Theranostics Health
  • Reveleris Flash Chromatography System Receives Patent from the Australian Patent Office
  • Sareum Receives Patent for one of its CHK1 Cancer Programme-related Inventions in the US
  • Lpath's iSONEP Receives Patent from USPTO
  • KeyGene Obtains Patent for High Throughput Screening in the US
  • BioInvent's F.I.R.S.T. Drug Discovery Technology Gets Patent in the US
  • Plasticell Receives Additional Patents for its CombiCult® Cell Culture Technology in the US, Europe, Australia and Singapore
  • EntomoPharm Receives Patent for its BBB Insect Model in Europe
  • Summit Gets Patent for Utrophin Modulator SMT C1100 in the US
  • USPTO Grants Patent to OncoMed for Methods of Treating Cancer with its Antibody Vantictumab
  • Novel Component of Phylomer® Peptide Platform Patented by Phylogica for Advanced Cell-Penetrating Drug Discovery
  • COTI Receives Two Newly Granted Patents for its Lead Oncology Asset in the US

4. KEY GLOBAL PLAYERS

  • 4-Antibody AG
  • Abbott Laboratories
  • Accelrys, Inc.
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Asahi Kasei Pharma Corporation
  • Astrazeneca Plc
  • Aviva Biosciences Corp.
  • Bayer Healthcare AG
  • BD Biosciences
  • Beckman Coulter Inc.
  • Biacore International AB
  • Bioanalytical Systems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Caliper Life Sciences, Inc.
  • Caprion Proteomics, Inc.
  • Celera Corporation
  • Celgene Corporation
  • Charles River Laboratories International, Inc.
  • Compugen Ltd.
  • Decode Genetics, Inc.
  • EMD Millipore Corporation
  • Evotec AG
  • GE Healthcare Ltd.
  • Genedata AG
  • Hitgen Ltd
  • Hudson Robotics, Inc.
  • Illumina Inc.
  • Incyte Corporation
  • Isis Pharmaceuticals, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Luminex Corporation
  • Maxcyte, Inc
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • Molecular Devices, LLC
  • Molecular Discovery Ltd.
  • Molecular Discovery Systems Pty., Ltd.
  • New England Biolabs, Inc.
  • Novartis AG
  • Osiris Therapeutics Inc.
  • Perkinelmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Quantum Pharmaceuticals
  • Roche Holding AG
  • Shimadzu Corporation
  • Sigma-Aldrich Corporation
  • Sri Biosciences
  • Tecan Group Ltd.
  • The National Center for Drug Screening
  • Thermo Fisher Scientific Inc.
  • Viva Biotech Ltd
  • Waters Corp.

5. KEY BUSINESS TRENDS

  • Evotec Established Alliance with Eternygen on New Small Molecule Inhibitors Development
  • MRC Technology Partnered With Daiichi Sankyo to Discover New Drug Targets
  • Evotec, Debiopharm Group® to Discover New Drugs to treat Cancer
  • Daiichi Sankyo Forms Alliance with UCSF on New Cures Development to Treat Neurodegenerative Diseases
  • Debut of a Synergetic Drug Discovery Project for 2014 by Daiichi Sankyo
  • Analgesic Drug Discovery and Development Collaboration Formed by Convergence and Evotec
  • MIT SBC, Pfizer Enter into a Three-Year Drug Discovery Research Alliance
  • Abide, Celgene Partners to Discover and Develop Novel Drugs to Treat Inflammation and Immunological Disorders
  • Novel Genetic Platform Having the Ability to Yield Natural Microbial Genomes
  • Johnson & Johnson Innovation Signs Novel Agreements with NEOMED and MaRS Innovation
  • Boehringer Ingelheim and Circuit Therapeutics Form Drug Discovery Research Pact for Three Years
  • Life Technologies and NCATS form RNAi Research Alliance to Enhance Novel Therapeutics Discovery
  • Novel Core Unit of USTAR and U of U Eases Pharmacological Therapeutic Development
  • JHL Biotech Inks Strategic Collaboration with Selexis to Develop Biologic Drugs
  • Bayer Offer Funding to the SGC for Expediting Drug Research
  • HitGen, the University of Manchester's Cancer Research UK Manchester Institute Drug Discovery Group and Cancer Research Technology Form Drug Discovery Pact
  • BioFocus, Boehringer Ingelheim Enter Into Drug Discovery Pact
  • Evotec Establishes Drug Discovery Alliance with Johnson & Johnson Innovation on AD Targets
  • Release of GE Healthcare Life Sciences' Novel Xuri® Technology Family
  • 4SC Discovery, CRELUX and AiCuris Form Drug Discovery Pact
  • Novel SLAP Technology for Drug Discovery Advancements
  • Inauguration of GE Healthcare Life Sciences Technology Laboratory at the UK's First Open Innovation Bioscience Campus
  • Debut of an "Open Innovation" Research Alliance by AstraZeneca and Taiwan's NRPB to Accelerate Drug Discovery
  • Asahi Kasei Pharma and Vernalis plc Collaborate to Discover Drugs for Autoimmune Diseases
  • Launch of Thermo Fisher Scientific's Novel Innovations at BioProcess International Conference and Exhibition
  • Adimab Establishes Alliance with Celgene on Multi-target Discovery
  • Eurofins Scientific, GE Healthcare Enter Pact on Drug Discovery Services
  • Debut of Boehringer Ingelheim and Polyphor into the Next Research Stage of their Alliance
  • Commercial Release of Agilent's RapidFire 365 High-Throughput Mass Spectrometry System
  • Zalicus Plans to Advance Clinical Development of Z944
  • Debut of Kinexus' DrugKiNET KnowledgeBase
  • Evotec Establishes Alliance with Harvard University to Develop Novel Antibacterial Agents
  • UCSF Turns to be the First Partner of Pfizer's CTI in Both Small-Molecule and Biologics Discovery
  • In-House Development of Various Novel Antiviral Drugs from Achillion
  • Launch of Thermo Fisher Scientific's Drug Discovery and Biopharma Production Innovations
  • Sareum Partners with SRI International for Advancing the Clinical Development of Tyrosine Kinase 2 Small Molecule Drug Discovery Program
  • Launch of Hudson Robotics' High Efficiency Screening, an Advanced Drug Discovery Technology
  • Accelrys Insight and Accelrys Insight for Excel Drug Discovery Softwares from Accelrys, Inc
  • Renewal of Evotec and Genentech's Drug Discovery Collaboration
  • Alchemia, AstraZeneca Form Multi-Target Drug Discovery Pact
  • RaQualia Establishes Research Alliance with Interprotein to Discover PPI Inhibitor
  • Collaborative Effort of Evotec and Ono Yields Novel Compounds for Preclinical Development
  • Galapagos Takeover Cangenix Assets
  • EMD Millipore's Novel Genomic Biomarker Services
  • Marketing of an Advanced Metabolite-Identification Platform by Agilent and Molecular Discovery
  • QuantiGene® ViewRNA Assay Platform-based Novel Cancer Biomarker Tests Co-developed by Affymetrix and MGH
  • Numerate and Merck Partnered to Discover Drug Leads for Cardiovascular Disease Target
  • Evotec Partners with IR Pharma to Offer Drug Discovery Solutions in the Area of Respiratory Diseases

6. GLOBAL MARKET OVERVIEW

  • 6.1. Global Market Overview by Technology
    • 6.1.1. Drug Discovery Technology Overview by Global Region
      • 6.1.1.1. Bioanalytical Assays
      • 6.1.1.2. Bioinformatics
      • 6.1.1.3. Cell Based Assays
      • 6.1.1.4. Genomic Technologies
      • 6.1.1.5. High Throughput Screening
      • 6.1.1.6. Proteomic Technologies
      • 6.1.1.7. Other Drug Discovery Technologies

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. THE UNITED STATES

  • 1.1. United States Market Overview by Technology
  • 1.2. Major Market Players
    • Abbott Laboratories
    • Accelrys, Inc.
    • Affymetrix Inc.
    • Agenus Inc.
    • Agilent Technologies Inc.
    • Albany Molecular Research, Inc.
    • Arqule Inc.
    • Aviva Biosciences Corp.
    • BD Biosciences
    • Beckman Coulter Inc.
    • Bioanalytical Systems, Inc.
    • Bio-Rad Laboratories, Inc.
    • Biovision, Inc.
    • Bristol-Myers Squibb Company
    • Bruker Corporation
    • Caliper Life Sciences, Inc.
    • Capital Genomix, Inc.
    • Celera Corporation
    • Celgene Corporation
    • Charles River Laboratories International, Inc.
    • Discoverx Corporation
    • Discovery Genomics, Inc.
    • EMD Millipore Corporation
    • Hudson Robotics, Inc.
    • Illumina Inc.
    • Incyte Corporation
    • Isis Pharmaceuticals, Inc.
    • Life Technologies Corporation
    • Luminex Corporation
    • Maxcyte, Inc
    • Merck & Co., Inc.
    • Millennium Pharmaceuticals, Inc.
    • Molecular Devices, LLC
    • New England Biolabs, Inc.
    • Osiris Therapeutics Inc.
    • Perkinelmer, Inc.
    • Promega Corporation
    • Sigma-Aldrich Corporation
    • SRI Biosciences
    • Thermo Fisher Scientific Inc.
    • Waters Corp.

2. EUROPE

  • 2.1. European Market Overview by Technology
  • 2.2. Major Market Players
    • 4-Antibody AG (Switzerland)
    • Astrazeneca Plc (United Kingdom)
    • Bayer Healthcare AG (Germany)
    • Biacore International AB (Sweden)
    • Biofocus Dpi, Ltd (United Kingdom)
    • Boehringer Ingelheim GmbH (Germany)
    • Decode Genetics, Inc. (Iceland)
    • Evotec AG (Germany)
    • GE Healthcare Ltd. (United Kingdom)
    • Genedata AG (Switzerland)
    • Molecular Discovery Ltd. (Italy)
    • Novartis AG (Switzerland)
    • Qiagen N.V. (The Netherlands)
    • Quantum Pharmaceuticals (Russia)
    • Roche Holding AG (Switzerland)
    • Tecan Group Ltd. (Switzerland)

3. ASIA-PACIFIC

  • 3.1. Asia-Pacific Market Overview by Technology
  • 3.2. Major Market Players
    • Asahi Kasei Pharma Corporation (Japan)
    • Hitgen Ltd (China)
    • Kyowa Hakko Kirin Co., Ltd. (Japan)
    • Molecular Discovery Systems Pty., Ltd. (Australia)
    • Shimadzu Corporation (Japan)
    • The National Center for Drug Screening (China)
    • Viva Biotech Ltd (China)

4. REST OF WORLD

  • 4.1. Rest of World Market Overview by Technology
  • 4.2. Major Market Players
    • Caprion Proteomics, Inc. (Canada)
    • Compugen Ltd. (Israel)
    • Pluristem Therapeutics Inc. (Israel)

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA

  • 1.1. Canada
  • 1.2. United States

2. EUROPE

  • 2.1. Belgium
  • 2.2. Denmark
  • 2.3. France
  • 2.4. Germany
  • 2.5. Iceland
  • 2.6. Ireland
  • 2.7. Italy
  • 2.8. Russia
  • 2.9. Sweden
  • 2.10. Switzerland
  • 2.11. The Netherlands
  • 2.12. The United Kingdom

3. ASIA-PACIFIC

  • 3.1. Australia
  • 3.2. China
  • 3.3. India
  • 3.4. Japan
  • 3.5. Singapore
  • 3.6. Taiwan

4. REST OF WORLD

  • 4.1. Israel

PART D: ANNEXURE

1. RESEARCH METHOLOGY

2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Drug Discovery Technologies Market Analysis (2010-2020) in USD Million
  • Chart 2: Global Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million
  • Chart 3: Glance at 2010, 2015 and 2020 Global Drug Discovery Technologies Market Share (%) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies
  • Chart 4: Global Market for Bioanalytical Assays in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 5: Glance at 2010, 2015 and 2020 Global Market Share of Bioanalytical Assays in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World
  • Chart 6: Global Market for Bioinformatics in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 7: Glance at 2010, 2015 and 2020 Global Market Share of Bioinformatics in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World
  • Chart 8: Global Market for Cell Based Assays in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 9: Glance at 2010, 2015 and 2020 Global Market Share of Cell Based Assays in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World
  • Chart 10: Global Market for Genomic Technologies in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 11: Glance at 2010, 2015 and 2020 Global Market Share of Genomic Technologies in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World
  • Chart 12: Global Market for High Throughput Screening in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 13: Glance at 2010, 2015 and 2020 Global Market Share of High Throughput Screening in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World
  • Chart 14: Global Market for Proteomic Technologies in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 15: Glance at 2010, 2015 and 2020 Global Market Share of Proteomic Technologies in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World
  • Chart 16: Global Market for Other Drug Discovery Technologies in Drug Discovery (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 17: Glance at 2010, 2015 and 2020 Global Market Share of Other Drug Discovery Technologies in Drug Discovery (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 18: The Projection of Largest Regions in terms of Market Growth for Drug Discovery Technologies by Geography ® Asia-Pacific, Europe and United States
  • Chart 19: Global Drug Discovery Technologies Market Analysis (2010-2020) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 20: Glance at 2010, 2015 and 2020 Global Drug Discovery Technologies Market Share (%) by Geographic Region ® United States, Europe, Asia-Pacific and Rest of World

THE UNITED STATES

  • Chart 21: United States Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million
  • Chart 22: Glance at 2010, 2015 and 2020 United States Drug Discovery Technologies Market Share (%) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

EUROPE

  • Chart 23: European Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million
  • Chart 24: Glance at 2010, 2015 and 2020 European Drug Discovery Technologies Market Share (%) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

ASIA-PACIFIC

  • Chart 25: Asia-Pacific Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million
  • Chart 26: Glance at 2010, 2015 and 2020 Asia-Pacific Drug Discovery Technologies Market Share (%) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

REST OF WORLD

  • Chart 27: Rest of World Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million
  • Chart 28: Glance at 2010, 2015 and 2020 Rest of World Drug Discovery Technologies Market Share (%) by Discovery Technology ® Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies
  • Table 1: Prominent Technologies used for Bioanalytical Research
  • Table 2: Prominent Types of Cell Based Assays used in High Throughput Screening
Back to Top